Control of type 2 diabetes mellitus: problems and prospects for their solution
Important medico-social and economic implications of type 2 diabetes mellitus (DM2) are determined by its continuously growing prevalence, frequencyand severity of complications related to inadequate glycemic control. Large-scale studies (UKPDS, VADT, ACCORD, ADVANCE) havedemonstrated controversial...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2009-12-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5703 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849730002174607360 |
|---|---|
| author | Tatiana Ivanovna Romantsova Irina Vladimirovna Glinkina |
| author_facet | Tatiana Ivanovna Romantsova Irina Vladimirovna Glinkina |
| author_sort | Tatiana Ivanovna Romantsova |
| collection | DOAJ |
| description | Important medico-social and economic implications of type 2 diabetes mellitus (DM2) are determined by its continuously growing prevalence, frequencyand severity of complications related to inadequate glycemic control. Large-scale studies (UKPDS, VADT, ACCORD, ADVANCE) havedemonstrated controversial effect of intensive glycemic control (estimated from HbA1c dynamics) on diabetic macrovascular complication. At thesame time, epidemiological, experimental, and observational studies yielded conclusive evidence of postprandial glycemia (PPG) contribution tooverall glycemic control and its role in the development of macrovascular complications. For this reason, PPG control is currently given as much attentionas traditional parameters (HbA1c and fasting glycemia). Dipeptidyl peptidase-IV (DPP-IV) inhibitors are a new class of hypoglycemic agentsthat raise levels of incretins, glucagons-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) in blood by suppressing DPPIVactivity. The resulting recovery of physiological insulin secretion promotes reduction of fasting and postprandial glycemia and HbA1c level. |
| format | Article |
| id | doaj-art-ebc3e71c7bb745a0bb455a04eded1eed |
| institution | DOAJ |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2009-12-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-ebc3e71c7bb745a0bb455a04eded1eed2025-08-20T03:09:00ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782009-12-01124424610.14341/2072-0351-57035661Control of type 2 diabetes mellitus: problems and prospects for their solutionTatiana Ivanovna Romantsova0Irina Vladimirovna Glinkina1I.M. Sechenov Moscow Medical Academy, MoscowI.M. Sechenov Moscow Medical Academy, MoscowImportant medico-social and economic implications of type 2 diabetes mellitus (DM2) are determined by its continuously growing prevalence, frequencyand severity of complications related to inadequate glycemic control. Large-scale studies (UKPDS, VADT, ACCORD, ADVANCE) havedemonstrated controversial effect of intensive glycemic control (estimated from HbA1c dynamics) on diabetic macrovascular complication. At thesame time, epidemiological, experimental, and observational studies yielded conclusive evidence of postprandial glycemia (PPG) contribution tooverall glycemic control and its role in the development of macrovascular complications. For this reason, PPG control is currently given as much attentionas traditional parameters (HbA1c and fasting glycemia). Dipeptidyl peptidase-IV (DPP-IV) inhibitors are a new class of hypoglycemic agentsthat raise levels of incretins, glucagons-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) in blood by suppressing DPPIVactivity. The resulting recovery of physiological insulin secretion promotes reduction of fasting and postprandial glycemia and HbA1c level.https://www.dia-endojournals.ru/jour/article/view/5703type 2 diabetes mellituspostprandial glycemiadpp-iv inhibitors |
| spellingShingle | Tatiana Ivanovna Romantsova Irina Vladimirovna Glinkina Control of type 2 diabetes mellitus: problems and prospects for their solution Сахарный диабет type 2 diabetes mellitus postprandial glycemia dpp-iv inhibitors |
| title | Control of type 2 diabetes mellitus: problems and prospects for their solution |
| title_full | Control of type 2 diabetes mellitus: problems and prospects for their solution |
| title_fullStr | Control of type 2 diabetes mellitus: problems and prospects for their solution |
| title_full_unstemmed | Control of type 2 diabetes mellitus: problems and prospects for their solution |
| title_short | Control of type 2 diabetes mellitus: problems and prospects for their solution |
| title_sort | control of type 2 diabetes mellitus problems and prospects for their solution |
| topic | type 2 diabetes mellitus postprandial glycemia dpp-iv inhibitors |
| url | https://www.dia-endojournals.ru/jour/article/view/5703 |
| work_keys_str_mv | AT tatianaivanovnaromantsova controloftype2diabetesmellitusproblemsandprospectsfortheirsolution AT irinavladimirovnaglinkina controloftype2diabetesmellitusproblemsandprospectsfortheirsolution |